- Investing Ideas
- /
- U.K. Pharmaceuticals & Biotech Financially Fit Penny Stocks
U.K. Pharmaceuticals & Biotech Financially Fit Penny Stocks
Results
18
A Penny Stocks screener, typically smaller or younger companies trading at a price below 5, with a focus on solid financial health that should present companies with a lower risk profile than other early-stage businesses
18 companies
Futura Medical
Market Cap: UK£30.1m
Research, develops, and sells pharmaceutical and healthcare products for sexual health.
FUM
UK£0.099
7D
7.1%
1Y
-72.7%
Diaceutics
Market Cap: UK£95.1m
A diagnostic commercialisation company, provides data, data analytics, and implementation services for pharmaceutical companies worldwide.
DXRX
UK£1.13
7D
0%
1Y
8.2%
ECO Animal Health Group
Market Cap: UK£35.6m
Develops, registers, and markets pharmaceutical products for animals worldwide.
EAH
UK£0.53
7D
0%
1Y
-44.7%
Theracryf
Market Cap: UK£4.8m
A clinical stage therapeutics company, engages in the development of therapeutics for oncology and behavioral brain disorders.
TCF
UK£0.0022
7D
0%
1Y
-71.0%
LungLife AI
Market Cap: UK£275.9k
A diagnostic company, researches and develops clinical diagnostic solutions for lung cancer with artificial intelligence (AI) technology in the United States and the People’s Republic of China.
LLAI
UK£0.009
7D
0%
1Y
-97.1%
Physiomics
Market Cap: UK£1.2m
Provides consulting services to pharmaceutical companies in the areas of outsourced quantitative pharmacology and computational biology in the United Kingdom, the United States, and the European Union Switzerland.
PYC
UK£0.004
7D
0%
1Y
-66.3%
N4 Pharma
Market Cap: UK£2.0m
A specialist pharmaceutical company, develops silica nanoparticle delivery systems to enhance the cellular delivery of cancer treatments, gene therapy, and vaccines in the United Kingdom.
N4P
UK£0.0037
7D
-11.8%
1Y
-48.3%
Oxford BioDynamics
Market Cap: UK£8.8m
Operates as a biotechnology company that discovers and develops biomarkers for use in the pharmaceutical and biotechnology industry primarily in the United States and the United Kingdom.
OBD
UK£0.0045
7D
5.9%
1Y
-94.9%
Poolbeg Pharma
Market Cap: UK£13.5m
Operates as a biopharmaceutical company, engages in the development and commercialization of medicines for unmet medical needs in the United Kingdom.
POLB
UK£0.027
7D
10.2%
1Y
-72.4%
Aptamer Group
Market Cap: UK£5.2m
Provides binders for research, diagnostics, and therapeutics in the United Kingdom, rest of Europe, the United States, and internationally.
APTA
UK£0.0026
7D
4.0%
1Y
-52.7%
Fusion Antibodies
Market Cap: UK£6.9m
A contract research organization, engages in the research, development, and manufacture of recombinant proteins and antibodies primarily for cancer and infectious diseases in the United Kingdom, the rest of Europe, North America, and internationally.
FAB
UK£0.066
7D
5.6%
1Y
61.7%
BSF Enterprise
Market Cap: UK£1.7m
Develops and commercializes cutting-edge tissue-engineered solutions.
BSFA
UK£0.014
7D
0%
1Y
-76.1%
Sareum Holdings
Market Cap: UK£23.4m
A clinical stage small molecule drug development company, engages in the discovery and development of therapeutic drugs for cancer and autoimmune diseases.
SAR
UK£0.17
7D
16.7%
1Y
20.7%
Nuformix
Market Cap: UK£1.8m
Together with its subsidiary, Nuformix Technologies Limited, operates in the field of pharmaceutical development for treating fibrosis and oncology through drug repurposing in the United Kingdom.
NFX
UK£0.0011
7D
-9.1%
1Y
-46.3%
SkinBioTherapeutics
Market Cap: UK£44.8m
A life science company, engages in research and development, and commercialization of technology that harnesses the microbiome for human health in the United Kingdom, the United States, Europe, and internationally.
SBTX
UK£0.19
7D
-18.9%
1Y
97.4%
ValiRx
Market Cap: UK£2.0m
A biopharmaceutical company, engages in the development of oncology therapeutics and companion diagnostics in the United Kingdom.
VAL
UK£0.0053
7D
26.5%
1Y
-85.6%
Arecor Therapeutics
Market Cap: UK£14.3m
A biopharmaceutical company, focuses on developing products in diabetes and other indications ion the United Kingdom.
AREC
UK£0.38
7D
0%
1Y
-72.4%
Cizzle Biotechnology Holdings
Market Cap: UK£6.1m
Develops an immunoassay test for the CIZ1B cancer biomarker for the early detection of lung cancer in the United Kingdom.
CIZ
UK£0.015
7D
10.7%
1Y
-11.4%